Depression in sickle cell disease

Syed Parwez Hasan1, Shahzad Hashmi, Mohammed Alhassen

  • 1Center for Sickle Cell Disease, Howard University Hospital, Washington, DC 20059, USA. phasan@hotmail.com

Insights

Depressive symptoms are prevalent in sickle cell disease patients, with 44% experiencing mild to severe depression. Factors like low income, female sex, and frequent crises contribute to higher depression rates, necessitating treatment to improve quality of life.

Area of Science:

  • Hematology
  • Psychiatry
  • Public Health

Background:

  • Sickle cell disease (SCD) is a chronic condition associated with significant health burdens.
  • Depressive symptoms are frequently observed in patients with chronic illnesses, impacting quality of life.
  • Understanding the prevalence and correlates of depression in SCD is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of depressive symptoms in sickle cell patients.
  • To identify demographic, disease severity, and healthcare utilization factors associated with depressive symptoms.
  • To examine these associations in patients stable for at least one month.

Main Methods:

  • A convenience sample of 50 sickle cell patients (27 men, 23 women) was recruited from a sickle cell clinic.
  • Depression was assessed using the Beck Depression Inventory (BDI) cut-off score.
  • Data on demographics, disease severity, and healthcare use were collected and analyzed.

Main Results:

  • 44% of sickle cell patients scored in the mild to severe range of depression (BDI > 20).
  • Depressed patients had higher rates of emergency room visits and hospitalizations for vaso-occlusive crises.
  • Factors associated with depression included low income, lower education, female sex, multiple blood transfusions, poor pain control, inadequate social support, hydroxyurea use, and frequent crises.

Conclusions:

  • The prevalence of depressive symptoms in sickle cell patients is high, exceeding that of the general African American population.
  • Findings align with previous research on depression in adults with sickle cell disease.
  • Treating depression is recommended to enhance quality of life and potentially improve disease outcomes in sickle cell patients.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
G Protein-coupled Receptors01:27

G Protein-coupled Receptors

G-protein-coupled receptors are ligand-binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that traverses the cell membrane seven times, creating intracellular and extracellular loops. The extracellular loops create a ligand-specific pocket which binds to neurotransmitters or hormones. The intracellular loops hold onto the G-protein.The G-protein, or guanine nucleotide-binding protein, is a large heterotrimeric complex. Its three subunits...